🇺🇸 Fluid resuscitation in United States

20 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 20

Most-reported reactions

1. Musculoskeletal Stiffness — 5 reports (25%)
2. Cellulitis — 2 reports (10%)
3. Drug Ineffective — 2 reports (10%)
4. Gait Disturbance — 2 reports (10%)
5. Inappropriate Schedule Of Product Administration — 2 reports (10%)
6. Pain — 2 reports (10%)
7. Thrombocytopenia — 2 reports (10%)
8. Abdominal Pain — 1 report (5%)
9. Acute Kidney Injury — 1 report (5%)
10. Aggression — 1 report (5%)

Source database →

Frequently asked questions

Is Fluid resuscitation approved in United States?

Fluid resuscitation does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Fluid resuscitation in United States?

Southeast University, China is the originator. The local marketing authorisation holder may differ — check the official source linked above.